Cargando…

Safety by design: Biosafety and biosecurity in the age of synthetic genomics

Technologies to profoundly engineer biology are becoming increasingly affordable, powerful, and accessible to a widening group of actors. While offering tremendous potential to fuel biological research and the bioeconomy, this development also increases the risk of inadvertent or deliberate creation...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Stefan A., Diggans, James, Densmore, Douglas, Dai, Junbiao, Knight, Tom, Leproust, Emily, Boeke, Jef D., Wheeler, Nicole, Cai, Yizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988571/
https://www.ncbi.nlm.nih.gov/pubmed/36895643
http://dx.doi.org/10.1016/j.isci.2023.106165
_version_ 1784901597818519552
author Hoffmann, Stefan A.
Diggans, James
Densmore, Douglas
Dai, Junbiao
Knight, Tom
Leproust, Emily
Boeke, Jef D.
Wheeler, Nicole
Cai, Yizhi
author_facet Hoffmann, Stefan A.
Diggans, James
Densmore, Douglas
Dai, Junbiao
Knight, Tom
Leproust, Emily
Boeke, Jef D.
Wheeler, Nicole
Cai, Yizhi
author_sort Hoffmann, Stefan A.
collection PubMed
description Technologies to profoundly engineer biology are becoming increasingly affordable, powerful, and accessible to a widening group of actors. While offering tremendous potential to fuel biological research and the bioeconomy, this development also increases the risk of inadvertent or deliberate creation and dissemination of pathogens. Effective regulatory and technological frameworks need to be developed and deployed to manage these emerging biosafety and biosecurity risks. Here, we review digital and biological approaches of a range of technology readiness levels suited to address these challenges. Digital sequence screening technologies already are used to control access to synthetic DNA of concern. We examine the current state of the art of sequence screening, challenges and future directions, and environmental surveillance for the presence of engineered organisms. As biosafety layer on the organism level, we discuss genetic biocontainment systems that can be used to created host organisms with an intrinsic barrier against unchecked environmental proliferation.
format Online
Article
Text
id pubmed-9988571
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99885712023-03-08 Safety by design: Biosafety and biosecurity in the age of synthetic genomics Hoffmann, Stefan A. Diggans, James Densmore, Douglas Dai, Junbiao Knight, Tom Leproust, Emily Boeke, Jef D. Wheeler, Nicole Cai, Yizhi iScience Review Technologies to profoundly engineer biology are becoming increasingly affordable, powerful, and accessible to a widening group of actors. While offering tremendous potential to fuel biological research and the bioeconomy, this development also increases the risk of inadvertent or deliberate creation and dissemination of pathogens. Effective regulatory and technological frameworks need to be developed and deployed to manage these emerging biosafety and biosecurity risks. Here, we review digital and biological approaches of a range of technology readiness levels suited to address these challenges. Digital sequence screening technologies already are used to control access to synthetic DNA of concern. We examine the current state of the art of sequence screening, challenges and future directions, and environmental surveillance for the presence of engineered organisms. As biosafety layer on the organism level, we discuss genetic biocontainment systems that can be used to created host organisms with an intrinsic barrier against unchecked environmental proliferation. Elsevier 2023-02-10 /pmc/articles/PMC9988571/ /pubmed/36895643 http://dx.doi.org/10.1016/j.isci.2023.106165 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hoffmann, Stefan A.
Diggans, James
Densmore, Douglas
Dai, Junbiao
Knight, Tom
Leproust, Emily
Boeke, Jef D.
Wheeler, Nicole
Cai, Yizhi
Safety by design: Biosafety and biosecurity in the age of synthetic genomics
title Safety by design: Biosafety and biosecurity in the age of synthetic genomics
title_full Safety by design: Biosafety and biosecurity in the age of synthetic genomics
title_fullStr Safety by design: Biosafety and biosecurity in the age of synthetic genomics
title_full_unstemmed Safety by design: Biosafety and biosecurity in the age of synthetic genomics
title_short Safety by design: Biosafety and biosecurity in the age of synthetic genomics
title_sort safety by design: biosafety and biosecurity in the age of synthetic genomics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988571/
https://www.ncbi.nlm.nih.gov/pubmed/36895643
http://dx.doi.org/10.1016/j.isci.2023.106165
work_keys_str_mv AT hoffmannstefana safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT diggansjames safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT densmoredouglas safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT daijunbiao safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT knighttom safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT leproustemily safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT boekejefd safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT wheelernicole safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics
AT caiyizhi safetybydesignbiosafetyandbiosecurityintheageofsyntheticgenomics